Costovertebral Mobilization on Kyphotic Posture and Lung Function in Non-Smoker

August 13, 2024 updated by: Riphah International University

Effects of Costovertebral Mobilization on Kyphotic Posture and Lung Function in Non Smoker

Aim of this study is to find the effects of Costoverterbral Mobilization on Thoracic kyphosis and Lung function in non-smoker. A randomized control trial that will include total 44 participants.The first group will receive Costovertebral Mobilization along with conventional therapy and 2nd group will receive conventional therapy.Data collected will be analyzed through SPSS 25

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Kyphosis is the curvature of the thoracic spine, formed by the shape of the vertebrae and the intervertebral discs and-in standing position-paraspinal muscle strength. Hyperkyphosis is usually associated with increased anteroposterior diameter of the thorax and a decrease in the distance between the xiphisternum and pubis and it is present when the kyphosis angle exceeds the normal ranges. This curve is concave anteriorly with a normal angle between 20˚ - 40˚.

The lungs are the foundational organs of the respiratory system,whose most basic function is to facilitate gas exchange from the environment into the bloodstream.The decline in lung function could be associated with hyperkyphosis, As the curvature of the thoracic spine increases and the posture becomes more hunched, the mobility of the rib cage could be limited and restrict the thoracic and lung expansions during inspiratory maneuver.

Different treatment strategies such as surgery, splinting, exercises and manual therapies such as massage, muscle energy technique, and passive joint mobilization have been used to treat hyperkyphosis. Costovertebral mobilization is a manual therapy technique, to improve the mobility and function of the joints between the ribs (costo) and the vertebrae (vertebral). This technique increases the range of motion of ribcage and spine, thus improve kyphosis posture and lung functions.

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
      • Islamabad, Pakistan, 44000
        • Recruiting
        • Madiha Ali
        • Contact:
        • Principal Investigator:
          • Rida Mumtaz, MSOMPT *

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Non smoker
  • Age: 20-40 years
  • Normal Body Mass Index 18.5 To 24.9
  • Both female and male gender
  • Decrease forced expiratory volume-one second/ forced vital capacity ratio greater than or equal to 70%
  • Increase Thoracic kyphotic posture greater than or equal to 40˚

Exclusion Criteria:

  • Any respiratory disease of the upper or lower respiratory tracts e.g. asthma, chronic bronchitis, COPD, emphysema etc. which could altered the optimal lung functioning.
  • Previous history of rib fractures, dislocations, sprains of costochondral, costosternal and interchondral joints.
  • Smokers
  • Scheuermann Disease
  • Primary and Secondary neoplastic lesions of the spine and/or ribs
  • Obvious advanced spinal deformity e.g. kyphoscoliosis
  • Infection e.g. tuberculosis
  • Primary and secondary neoplastic lesions of the soft tissue structures of the chest
  • Inflammation e.g. acute rheumatoid arthritis or ankylosing spondylitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Costovertebral Mobilization+Conventional Therapy

Costovertebral mobilization:

It will be performed in 3 Different Positions to target specific regions of rib cage.

Conventional Therapy:

Hot pack 10 mints, Posture corrective exercises, Breathing exercises.
Other: Costovertebral Mobilization+Conventional Therapy

Patient would receive costovertebral mobilization in side lying position for left 10th to 6th, in sitting position for right 10th to 2nd rib and in supine lying position for 1st rib.

Conventional Therapy:

Hot pack 10 mints, Posture corrective exercises, Breathing exercises Frequency; 4 times/week for 3 weeks
Other: Conventional Therapy

Conventional Therapy:

Hot pack 10 mints, Posture corrective exercises, Breathing exercises
Other: Conventional Therapy

Electrotherapy:

• Hot Pack 10 minutes

Posture Corrective Exercises:

  • Thoracic Rotation 10 rep/session
  • Thoracic extension 10 rep/session
  • Scapular retraction 5 rep/session
  • Deep neck flexor Isometric 5 rep/session

Deep Breathing Exercises:

• Pursed lip breathing 10 repetition in one session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
X-RAY
Time Frame: 3 weeks
X-ray is a gold standard method for objective assessment of Thoracic Kyphosis.
3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spirometer
Time Frame: 3 weeks
For measurement of forced expiratory volume-one second/ Forced vital capacity ratio (Pulmonary Function Tests).
3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Madiha Ali, MSOMPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2024

Primary Completion (Estimated)

December 30, 2024

Study Completion (Estimated)

January 10, 2025

Study Registration Dates

First Submitted

July 28, 2024

First Submitted That Met QC Criteria

July 28, 2024

First Posted (Actual)

July 31, 2024

Study Record Updates

Last Update Posted (Actual)

August 14, 2024

Last Update Submitted That Met QC Criteria

August 13, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Rida Mumtaz

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperkypohsis and Impaired Lung Function

Clinical Trials on Costovertebral Mobilization+Conventional Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe